Form EFFECT LUMOS PHARMA, INC.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 12, 2024 |
| Accession Number: | 0001193125-24-276550 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vatrer Power LiFePO4 Batteries Earn Intertek Certification to UL 2271 and UL 1973 Safety Standards
- ETH Price Prediction: Ethereum Recovery Creates a Stronger Market for MemeToro’s AI Presale
- The Next New Listing Could Crown This Cycle’s Biggest Winners and Smart Wallets Already Moved
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
